TickerFacts.

Company research / DLB

Dolby Laboratories, Inc. (DLB)

Build a valuation ↗↓ Download CSV

CIK 0001308547 · NYSE · Patent Owners & Lessors

  • Sector Finance & Real Estate
  • Incorporated DE
  • Fiscal year ends around Sep 27

For the year ended 2025-09-26, Dolby Laboratories, Inc. reported revenue of $1.35B. Revenue grew 5.9% from the prior annual period. Over the twelve months to 2026-06-26, revenue was $1.35B.

Key ratios (year ended 2025-09-26)

88.1%
Gross margin
19.6%
Operating margin
18.9%
Net margin
9.7%
Return on year-end equity
5.9%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-05

Headquarters locality: San Francisco · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-26 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-26		2025-09-262024-09-272023-09-292022-09-302021-09-242020-09-252019-09-272018-09-282017-09-292016-09-30
Revenue$1.35B$1.35B$1.27B$1.30B$1.25B$1.28B$1.16B$1.24B$1.05B$1.08B$1.03B
Cost of Revenue$167.78M$160.13M$140.50M$152.57M$141.36M$130.03M$146.50M$160.85M$127.56M$118.53M$108.98M
Gross Profit$1.19B$1.19B$1.13B$1.15B$1.11B$1.15B$1.02B$1.08B$927.04M$961.65M$916.76M
R&D Expense$265.94M$261.79M$263.66M$271.52M$261.17M$253.64M$239.04M$237.87M$236.79M$233.31M$219.61M
Operating Income$239.10M$264.96M$258.33M$215.75M$206.60M$344.39M$218.74M$257.08M$183.50M$247.13M$231.79M
Depreciation & Amortization$92.84M$87.83M$75.56M$82.56M$88.46M$95.86M$90.88M$85.12M$81.28M$84.31M$85.15M
EBITDA$331.94M$352.79M$333.88M$298.31M$295.07M$440.25M$309.62M$342.20M$264.79M$331.44M$316.95M
Net Income$226.18M$255.02M$261.82M$200.66M$184.09M$310.23M$231.36M$255.15M$41.75M$206.48M$185.86M
EPS (Diluted)n/a$2.62$2.69$2.05$1.81$2.97$2.25$2.44$0.39$2.00$1.81
Total Assets$3.16B$3.23B$3.11B$2.98B$2.69B$3.11B$2.92B$2.82B$2.87B$2.53B$2.31B
Total Liabilities$563.89M$595.81M$623.03M$607.58M$438.53M$501.45M$478.92M$508.72M$494.88M$389.71M$331.37M
Shareholders' Equity$2.59B$2.63B$2.49B$2.37B$2.25B$2.60B$2.44B$2.31B$2.37B$2.40B$1.98B
Cash & Equivalents$669.39M$701.89M$482.05M$745.36M$620.13M$1.23B$1.07B$797.21M$918.06M$634.37M$516.11M
Operating Cash Flow$437.60M$472.20M$327.25M$367.08M$318.58M$447.75M$343.85M$327.67M$352.20M$377.79M$360.06M
Capital Expenditures$44.92M$36.35M$30.01M$30.34M$47.93M$54.45M$66.35M$96.28M$72.81M$99.62M$100.76M
Free Cash Flow$392.67M$435.85M$297.25M$336.74M$270.65M$393.30M$277.50M$231.39M$279.39M$278.18M$259.30M
Share Repurchases$235.00M$124.99M$160.00M$149.28M$530.49M$245.86M$173.74M$340.58M$150.47M$100.00M$100.85M
Dividends Paid$134.25M$126.60M$114.58M$103.41M$100.07M$89.17M$88.58M$77.50M$66.16M$57.06M$48.40M
Dividends Per Sharen/a$1.32$1.23$1.11$1.02$0.91$0.88$0.79$0.67$0.58$0.50
Weighted Average Diluted Sharesn/a97.48M97.33M97.73M101.98M104.62M102.94M104.57M106.98M103.29M102.42M
EPS (Basic)n/a$2.66$2.74$2.10$1.84$3.07$2.30$2.51$0.40$2.03$1.85

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView